Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 47, 2012 - Issue 2
Submit an article Journal homepage
483
Views
51
CrossRef citations to date
0
Altmetric
Liver and Biliary Disease

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors

Tomas Koller5th Internal Medicine Department, Comenius University Medical School, University Hospital Bratislava, Bratislava, SlovakiaCorrespondence[email protected]
,
Jana Kollerova5th Internal Medicine Department, Comenius University Medical School, University Hospital Bratislava, Bratislava, Slovakia
,
Tibor Hlavaty5th Internal Medicine Department, Comenius University Medical School, University Hospital Bratislava, Bratislava, Slovakia
,
Martin Huorka5th Internal Medicine Department, Comenius University Medical School, University Hospital Bratislava, Bratislava, Slovakia
&
Juraj Payer5th Internal Medicine Department, Comenius University Medical School, University Hospital Bratislava, Bratislava, Slovakia
Pages 197-203 | Received 02 Apr 2011, Accepted 18 Nov 2011, Published online: 19 Dec 2011

References

  • Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230–9.
  • Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006;20:981–96.
  • Tsai CHJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr 2004;80:38–44.
  • Pagliarulo M, Fornari F, Fraquelli M, Zoli M, Giangregorio F, Grigolon A, Gallstone disease and related risk factors in a large cohort of diabetic patients. Dig Liver Dis 2004;36:130–4.
  • Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004;80:1–2.
  • Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez Baptista H, Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005;11:1653–7.
  • Koller T, Kollerová J, Hlavatý T, Huorka M, Payer J. Prevalence of liver disease markers among patients with metabolic risk factors. Vnitr Lek 2010;56:183–9.
  • deAlwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48(Suppl 1):S104–12.
  • Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008;51:1947–53.
  • Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372–84.
  • Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007;13:1579–84.
  • Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, Pérez-Morales AG, Martinez S, Cid-Juarez S. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg 2008;12:2097–102.
  • Ioannou GN. Cholelithiasis. cholecystectomy. and liver disease. Am J Gastroenterol 2010;105:1364–73.
  • Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005;20:1176–84.
  • Fraenkel E, Takács R, Hamvas J, Lengyel G, Fehér J. Common occurrence ofnon-alcoholic fatty liver disease and cholecystolithiasis. Orv Hetil 2007;148:793–8.
  • Kovacs P, Kurtz U, Wittenburg H. Hepatic insulin resistance ties cholesterol gallstone formation and the metabolic syndrome. Annals of Hepatology. 2008;7:262–4.
  • Yang ZX, Shen W, Sun H. Effects of nuclear receptor FXR on the regulation of the liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 2010;4:741–8.
  • Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholicfatty liver disease and metabolic syndrome. J Dig Dis 2011;12:125–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.